Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2015: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2014: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2013: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
Outline of Final Research Achievements |
The aim of this study was to clarify the role of uPA/uPAR on the inflammatory bone loss. We found that uPA attenuated inflammatory osteoclastogenesis through the activation of AMPK. Additionally, we found that uPAR regulated inflammatory osteoclastogenesis through the integrin/Akt pathway. Moreover, we found that uPAR regulated inflammation-induced TNF-α production. These data suggest that uPA/uPAR plays an important roles on the inflammatory bone loss.
|